Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron supplementation for lead toxicity prevention in infants
NCT00374790Phase 2Completed
- Sponsor
- Cornell University
- Start
- Oct 2006
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ferrous sulfate in lead poisoning, sponsored by Cornell University. Primary endpoints: Incidence of blood lead concentrations > 10 mcg/dL at 6 months and Mean hemoglobin concentration at 6 months. Started Oct 2006; status: completed.
02
Drugs
ferrous sulfate
03
Conditions
lead poisoning
Beyond the preview
Go deeper on NCT00374790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00374790.